Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

May 30, 2008

Primary Completion Date

April 18, 2019

Study Completion Date

April 1, 2020

Conditions
Type 2 Diabetes
Interventions
DRUG

Placebo

Subcutaneous injection, twice a day

DRUG

Exenatide

Subcutaneous injection, 5 µg, twice a day

DRUG

Exenatide

Subcutaneous injection,10 µg, twice a day

Trial Locations (53)

1022

Research Site, Moloto South

1100

Research Site, Quezon City

4345

Research Site, Verulam

7626

Research Site, Paarl

11432

Research Site, Jamaica

20127

Research Site, Aguascalientes

27610

Research Site, Raleigh

27834

Research Site, Greenville

30721

Research Site, Dalton

32308

Research Site, Tallahassee

32504

Research Site, Pensacola

32806

Research Site, Orlando

32901

Research Site, Melbourne

33014

Research Site, Miami Lakes

33144

Research Site, Miami

35233

Research Site, Birmingham

38401

Research Site, Memphis

44650

Research Site, Guadalajara

46202

Research Site, Indianapolis

48124

Research Site, Dearborn

60612

Research Site, Chicago

60637

Research Site, Chicago

63104

Research Site, St Louis

64108

Research Site, Kansas City

64710

Research Site, Monterrey

67226

Research Site, Wichita

75235

Research Site, Dallas

76800

Research Site, San Juan del Río

78207

Research Site, San Antonio

80045

Research Site, Aurora

80200

Research Site, Culiacán

85724

Research Site, Tucson

87070

Research Site, Tamaupilas

89170

Research Site, Tampico

89502

Research Site, Reno

90048

Research Site, Los Angeles

91763

Research Site, Montclair

92123

Research Site, San Diego

92707

Research Site, Santa Ana

95819

Research Site, Sacramento

99202

Research Site, Spokane

125373

Research Site, Moscow

380006

Research Site, Ahmedabad

450077

Research Site, Ufa

634050

Research Site, Tomsk

73104-5008

Research Site, Oklahoma City

60430-370

Research Site, Fortaleza

36025-330

Research Site, Juiz de Fora

09030-010

Research Site, Santo André

Unknown

Research Site, Bangalore

Research Site, Pune

Research Site, Seoul

0087

Research Site, Pretoria

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

AstraZeneca

INDUSTRY